[1]
|
Globocan (2012) Estimated Cancer Incidence, Mortality, and Prevalence Worldwide 2012 International Agency for Research on Cancer.
http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx
|
[2]
|
Hussain, S.M.A. (2013) Comprehensive Update on Cancer Scenario of Bangladesh. South Asian Journal of Cancer, 2, 279-284.
https://doi.org/10.4103/2278-330X.119901
|
[3]
|
Worldometer (2018) Bangladesh Population.
http://www.worldometers.info/world-population/bangladesh-population/
|
[4]
|
Hussain, S.A. and Sullivan, R. (2013) Cancer Control in Bangladesh. Japanese Journal of Clinical Oncology, 43, 1159-1169. https://doi.org/10.1093/jjco/hyt140
|
[5]
|
Hwang, Y.Y., Moon, H., Cho, S.H., Kim, K.T., Moon, Y.J., Kim, S.R., et al. (2001) Ten-Year Survival of Patients with Locally Advanced, Stage Ib-IIb Cervical Cancer after Neoadjuvant Chemotherapy and Radical Hysterectomy. Gynecologic Oncology, 82, 88-93. https://doi.org/10.1006/gyno.2001.6204
|
[6]
|
Liu, Y.M., Ni, L.Q., Wang, S.S., Lv, Q.L., Chen, W.J. and Ying, S.P. (2018) Outcome and Prognostic Factors in Cervical Cancer Patients Treated with Surgery and Concurrent Chemoradiotherapy: A Retrospective Study. World Journal of Surgical Oncology, 16, 18. https://doi.org/10.1186/s12957-017-1307-0
|
[7]
|
Grover, S., Xu, M.J., Yeager, A., Rosman, L., Groen, R.S., Chackungal, S., Rodin, D., Mangaali, M., Nurkic, S., Fernandes, A., Lin, L.L., Thomas, G. and Tergas, A.I. (2015) A Systematic Review of Radiotherapy Capacity in Low- and Middle-Income Countries. Frontiers in Oncology, 4, 1-11. https://doi.org/10.3389/fonc.2014.00380
|
[8]
|
Chuang, L., Kanis, M.J., Miller, B., Wright, J., Small Jr., W. and Creasman, W. (2016) Treating Locally Advanced Cervical Cancer With Concurrent Chemoradiation without Brachytherapy in Low-Resource Countries. American Journal of Clinical Oncology, 39, 92-97. https://doi.org/10.1097/COC.0000000000000222
|
[9]
|
Scarabelli, C., Zarrelli, A., Gallo, A. and Visentin, M.C. (1995) Multimodaltreatment with Neoadjuvantintraarterial Chemotherapy Andradical Surgery in Patients with Stage IIIB-IVA Cervical Cancer: A Preliminary Study. Cancer, 76, 1019-1026.
https://doi.org/10.1002/1097-0142(19950915)76:6<1019::AID-CNCR2820760616>3.0.CO;2-4
|
[10]
|
Sardi, J., Sananes, C., Giaroli, A., Maya, G. and di Paola, G. (1990) Neoadjuvant Chemotherapy in Locally Advanced Carcinoma of the Cervix Uteri. Gynecologic Oncology, 38, 486-493.
https://doi.org/10.1016/0090-8258(90)90096-4
|
[11]
|
Uddin, A.F.M.K., Khan, Z.J., Islam, J. and Mahmud, A. (2013) Cancer Care Scenario in Bangladesh. South Asian Journal of Cancer, 2, 102-104.
https://doi.org/10.4103/2278-330X.110510
|
[12]
|
Sharma, V., Kerr, S.H., Kawar, Z. and Kerr, D.J. (2011) Challenges of Cancer Control in Developing Countries; Current Status and Future Perspective. Future Oncology, 7, 1213-1222.
|
[13]
|
Therasse, P., Mauriac, L., Welnicka-Jaskiewicz, M., Bruning, P., Cufer, T., Bonnefoi, H., Tomiak, E., Pritchard, K.I., Hamilton, A., Piccart, M.J. EORTC (2003) Final Results of a Randomized Phase III Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil with a Dose-Intensified Epirubicin and Cyclophosphamide + Filgrastim as Neoadjuvant Treatment in Locally Advanced Breast Cancer: An EORTC-NCIC-SAKK Multicenter Study. Journal of Clinical Oncology, 21, 843-850.
https://doi.org/10.1200/JCO.2003.05.135
|
[14]
|
Kawano, M., Mabuchi, S., Matsumoto, Y., Sasano, T., Takahashi, R., Kuroda, H., Kimura, T., et al. (2015) The Significance of G-CSF Expression and Myeloid-Derived Suppressor Cells in the Chemoresistance of Uterine Cervical Cancer. Scientific Reports, 5, Article No. 18217.
|
[15]
|
Markman, M. (2014) Advances in Cervical Cancer Pharmacotherapies. Expert Review of Clinical Pharmacology, 7, 219-223.
https://doi.org/10.1586/17512433.2014.884924
|
[16]
|
Bangabandhu Sheikh Mujib Medical University (BSMMU) (2018).
http://www.bsmmu.edu.bd/
|
[17]
|
Therasse, P., Arbuck, S.G., Eisenhauer, E.A., Wanders, J., Kaplan, R.S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A.T., Christian, M.C., et al. (2000) New Guidelines to Evaluate the Response to Treatment in Solid Tumors. JNCI: Journal of the National Cancer Institute, 92, 205-216.
https://doi.org/10.1093/jnci/92.3.205
|
[18]
|
Chou, H.H., Huang, H.J., Lin, H., Yang, L.Y., Hsueh, S., Liu, F.Y., Liou, Y.L., Liou, J.D., Chen, M.Y., Chao, A., Lin, G., Chang, T.C. and Lai, C.H. (2014) Phase I Dose-Escalation Study of Weekly Paclitaxel and Cisplatin Followed by Radical Hysterectomy in Stages IB2 and IIA2 Cervical Cancer. American Journal Clinical Oncology, 40, 241-249.
|
[19]
|
Duenas-Gonzalez, A., Lopez-Graniel, C., Gonzalez-Enciso, A., Cetina, L., Rivera, L., Mariscal, I., et al. (2003) A Phase II Study of Multimodality Treatment for Locally Advanced Cervical Cancer: Neoadjuvant Carboplatin and Paclitaxel Followed by Radical Hysterectomy and Adjuvant Chemoradiation. Annals of Oncology, 14, 1278-1284. https://doi.org/10.1093/annonc/mdg333
|
[20]
|
Lapresa, M., Parma, G., Portuesi, R. and Colombo, N. (2015) Neoadjuvant Chemotherapy in Cervical Cancer: An Update. Expert Review of Anticancer Therapy, 15, 1171-1181. https://doi.org/10.1586/14737140.2015.1079777
|
[21]
|
Islam, S.M.S., Lechner, A., Ferrari, U., Froeschl, G., Alam, D. S., Holle, R., Niessen, L.W., et al. (2014) Mobile Phone Intervention for Increasing Adherence to Treatment for Type 2 Diabetes in an Urban Area of Bangladesh: Protocol for a Randomized Controlled Trial. BMC Health Services Research, 14, 586.
https://doi.org/10.1186/s12913-014-0586-1
|
[22]
|
Peters, W.A., Liu, P.Y., Barrett, R.J., et al. (2000) Concurrent Chemotherapy and Pelvic Radiation Therapy Compared with Pelvic Radiation Therapy Alone as Adjuvant Therapy after Radical Surgery in High-Risk Early-Stage Cancer of the Cervix. Journal of Clinical Oncology, 18, 1606-1613.
https://doi.org/10.1200/JCO.2000.18.8.1606
|
[23]
|
Keys, H.M., Bundy, B.N., Stehman, F.B., et al. (1999) Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma. New England Journal of Medicine, 340, 1154-1161. https://doi.org/10.1056/NEJM199904153401503
|
[24]
|
Rose, P.G., Bundy, B.N., Watkins, E.B., et al. (1999) Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer. New England Journal of Medicine, 340, 1144-1153.
https://doi.org/10.1056/NEJM199904153401502
|
[25]
|
Morris, M., Eifel, P.J., Lu, J., et al. (1999) Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer. New England Journal of Medicine, 340, 1137-1143.
https://doi.org/10.1056/NEJM199904153401501
|
[26]
|
Whitney, C.W., Sause, W., Bundy, B.N., et al. (1999) Randomized Comparison of Fluorouracil plus Cisplatin versus Hydroxyurea as an Adjunct to Radiation Therapy in Stage IIBYIVA Carcinoma of the Cervix with Negative Para-Aortic Lymph Nodes: A Gynecologic Oncology Group and Southwest Oncology Group Study. Journal of Clinical Oncology, 17, 1339-1348.
https://doi.org/10.1200/JCO.1999.17.5.1339
|
[27]
|
(NACT) Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-analysis Collaboration (2003) Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data from 21 Randomized Trials. European Journal of Cancer, 39, 2470-2486.
|
[28]
|
Osman, M. (2014) The Role of Neoadjuvant Chemotherapy in the Management of Locally Advanced Cervix Cancer: A Systematic Review. Oncology Reviews, 28, 250.
https://doi.org/10.4081/oncol.2014.250
|
[29]
|
Rydzewska, L., Tierney, J., Vale, C.L. and Symonds, P.R. (2010) Neoadjuvant Chemotherapy plus Surgery versus Surgery for Cervical Cancer. Cochrane Database System Review, CD007406.
|
[30]
|
Kokka, F., Bryant, A., Brockbank, E., Powell, M. and Oram, D. (2015) Hysterectomy with Radiotherapy or Chemotherapy or Both for Women with Locally Advanced Cervical Cancer. Cochrane Database Systematic Reviews, 7, CD010260.
|
[31]
|
Eddy, G.L., Bundy, B.N., Creasman, W.T. and Soirtos, N.M. (2007) Treatment of (“Bulky”) Stage Ib Cervical Cancer with or without Neoadjuvant Vincristine and Cisplatin Prior to Radical Hysterectomy and Pelvic/Para-Aortic Lymphadenectomy: A Phase III Trial of the Gynecologic Oncology Group. Gynecologic Oncology, 106, 362-369. https://doi.org/10.1016/j.ygyno.2007.04.007
|
[32]
|
Gupta, S., Maheshwari, A., Parab, P., Mahantshetty, U., Hawaldar, R., Sastri Chopra, S., Kerkar, R., Engineer, R., Tongaonkar, H., Ghosh, J., Gulia, S., Kumar, N., Shylasree, T.S., Gawade, R., Kembhavi, Y., Gaikar, M., Menon, S., Thakur, M., Shrivastava, S. and Badwe, R. (2018) Neoadjuvant Chemotherapy Followed by Radical Surgery versus Concomitant Chemotherapy and Radiotherapy in Patients with Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial. Journal of Clinical Oncology.
|
[33]
|
Haque, N., Uddin, A.F.M.K., Dey, B.R., Islam, F. and Goodman, A. (2017) Challenges to Cervical Cancer Treatment in Bangladesh: The Development of a Women’s Cancer Ward at Dhaka Medical College Hospital. Gynecologic Oncology Reports, 21, 67-72. https://doi.org/10.1016/j.gore.2017.06.001
|